Common Stock, Shares, Outstanding of Innovation1 Biotech Inc. from 31 Aug 2015 to 29 Feb 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Innovation1 Biotech Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Aug 2015 to 29 Feb 2024.
  • Innovation1 Biotech Inc. Common Stock, Shares, Outstanding for the quarter ending 29 Feb 2024 was 22,470,239, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Innovation1 Biotech Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 22,470,239 +2,450,000 +12% 29 Feb 2024 10-Q 06 May 2025 2024 Q2
Q4 2023 22,470,239 +2,450,000 +12% 30 Nov 2023 10-Q 27 Jan 2025 2023 Q1
Q3 2023 20,470,239 +450,000 +2.2% 31 Aug 2023 10-Q 06 May 2025 2024 Q2
Q2 2023 20,470,239 +450,000 +2.2% 31 May 2023 10-Q 13 Sep 2023 2023 Q3
Q1 2023 20,020,239 0 0% 28 Feb 2023 10-Q 30 May 2023 2023 Q2
Q4 2022 20,020,239 0 0% 30 Nov 2022 10-Q 17 Jan 2023 2023 Q1
Q3 2022 20,020,239 +19,831,623 +10514% 31 Aug 2022 10-K 17 Jan 2024 2023 FY
Q2 2022 20,020,239 +19,831,623 +10514% 31 May 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 20,020,239 +19,831,623 +10514% 28 Feb 2022 10-Q 15 Apr 2022 2022 Q2
Q4 2021 20,020,239 +19,833,045 +10595% 30 Nov 2021 10-Q/A 01 Feb 2022 2022 Q1
Q3 2021 188,616 +1,422 +0.76% 31 Aug 2021 10-K 15 Dec 2022 2022 FY
Q2 2021 188,616 -57,448,104 -100% 31 May 2021 10-Q 13 Jul 2021 2021 Q3
Q1 2021 188,616 -57,448,104 -100% 28 Feb 2021 10-Q 14 Apr 2021 2021 Q2
Q4 2020 187,194 -135,322,026 -100% 30 Nov 2020 10-Q 13 Jan 2021 2021 Q1
Q3 2020 187,194 -135,093,457 -100% 31 Aug 2020 10-K 10 Dec 2021 2021 FY
Q2 2020 57,636,720 -76,263,410 -57% 31 May 2020 10-Q 20 Jul 2020 2020 Q3
Q1 2020 57,636,720 -75,467,823 -57% 29 Feb 2020 10-Q 20 Apr 2020 2020 Q2
Q4 2019 135,509,220 +2,871,720 +2.2% 30 Nov 2019 10-Q 21 Jan 2020 2020 Q1
Q3 2019 135,280,651 +2,643,151 +2% 31 Aug 2019 10-K 15 Dec 2020 2020 FY
Q2 2019 133,900,130 +1,034,059 +0.78% 31 May 2019 10-Q 18 Jul 2019 2019 Q3
Q1 2019 133,104,543 +238,472 +0.18% 28 Feb 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 132,637,500 -85,715 -0.06% 30 Nov 2018 10-Q 18 Jan 2019 2019 Q1
Q3 2018 132,637,500 +70,000,000 +112% 31 Aug 2018 10-K 17 Dec 2019 2019 FY
Q2 2018 132,866,071 +80,228,571 +152% 31 May 2018 10-Q 23 Jul 2018 2018 Q3
Q1 2018 132,866,071 +80,228,571 +152% 28 Feb 2018 10-Q 23 Apr 2018 2018 Q2
Q4 2017 132,723,215 +80,085,715 +152% 30 Nov 2017 10-Q 22 Jan 2018 2018 Q1
Q3 2017 62,637,500 +10,000,000 +19% 31 Aug 2017 10-K 14 Dec 2018 2018 FY
Q2 2017 52,637,500 0 0% 31 May 2017 10-Q 24 Jul 2017 2017 Q3
Q1 2017 52,637,500 0 0% 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 52,637,500 +47,637,500 +953% 30 Nov 2016 10-Q 17 Jan 2017 2017 Q1
Q3 2016 52,637,500 +20,137,500 +62% 31 Aug 2016 10-K/A 19 Jan 2018 2017 FY
Q2 2016 52,637,500 31 May 2016 10-Q 07 Oct 2016 2016 Q3
Q1 2016 52,637,500 15 Mar 2016 10-K/A 19 Jan 2018 2017 FY
Q4 2015 5,000,000 30 Nov 2015 10-Q 12 Feb 2016 2016 Q1
Q3 2015 32,500,000 31 Aug 2015 10-K 06 Dec 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.